Avecho Biotechnology Limited (AVE.AX)
AUD 0.01
(25.0%)
AUD 0.01
(25.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 473.55 Thousand AUD | -58.07% |
| 2022 | 1.12 Million AUD | 42.3% |
| 2021 | 793.6 Thousand AUD | 106.33% |
| 2020 | 384.62 Thousand AUD | -90.92% |
| 2019 | 4.23 Million AUD | 203.97% |
| 2018 | 1.39 Million AUD | 21.2% |
| 2017 | 1.15 Million AUD | -27.57% |
| 2016 | 1.58 Million AUD | -27.48% |
| 2015 | 2.19 Million AUD | 18.57% |
| 2014 | 1.84 Million AUD | 34.23% |
| 2013 | 1.37 Million AUD | 7.17% |
| 2012 | 1.28 Million AUD | -48.97% |
| 2011 | 2.51 Million AUD | -46.01% |
| 2010 | 4.66 Million AUD | 378.44% |
| 2009 | 974 Thousand AUD | -61.16% |
| 2008 | 2.5 Million AUD | 58.13% |
| 2007 | 1.58 Million AUD | 15.01% |
| 2006 | 1.37 Million AUD | 649.46% |
| 2005 | 184 Thousand AUD | 0.0% |
| 2004 | - AUD | -100.0% |
| 2003 | 240.2 Thousand AUD | 72.79% |
| 2002 | 139.01 Thousand AUD | 0.0% |
| 2001 | - AUD | 0.0% |
| 2000 | - AUD | 0.0% |
| 1999 | - AUD | 0.0% |
| 1998 | - AUD | 0.0% |
| 1997 | - AUD | 0.0% |
| 1996 | - AUD | 0.0% |
| 1995 | - AUD | 0.0% |
| 1994 | - AUD | 0.0% |
| 1993 | - AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 312.18 Thousand AUD | 0.0% |
| 2023 Q2 | 446.43 Thousand AUD | 0.0% |
| 2023 FY | 473.55 Thousand AUD | -58.07% |
| 2023 Q4 | 27.11 Thousand AUD | 0.0% |
| 2022 Q4 | 371.02 Thousand AUD | 0.0% |
| 2022 Q2 | 758.23 Thousand AUD | 0.0% |
| 2022 FY | 1.12 Million AUD | 42.3% |
| 2021 Q2 | 265.89 Thousand AUD | 0.0% |
| 2021 Q4 | 527.7 Thousand AUD | 0.0% |
| 2021 FY | 793.6 Thousand AUD | 106.33% |
| 2020 Q4 | 187.63 Thousand AUD | 0.0% |
| 2020 FY | 384.62 Thousand AUD | -90.92% |
| 2020 Q2 | 196.98 Thousand AUD | 0.0% |
| 2019 Q2 | 4.17 Million AUD | 0.0% |
| 2019 Q4 | 61.91 Thousand AUD | 0.0% |
| 2019 FY | 4.23 Million AUD | 203.97% |
| 2018 FY | 1.39 Million AUD | 21.2% |
| 2018 Q2 | 819.89 Thousand AUD | 0.0% |
| 2018 Q4 | 574.38 Thousand AUD | 0.0% |
| 2017 FY | 1.15 Million AUD | -27.57% |
| 2017 Q2 | 812.62 Thousand AUD | 0.0% |
| 2016 FY | 1.58 Million AUD | -27.48% |
| 2016 Q4 | 282.25 Thousand AUD | 0.0% |
| 2016 Q2 | 1.3 Million AUD | 0.0% |
| 2015 FY | 2.19 Million AUD | 18.57% |
| 2015 Q4 | 1.21 Million AUD | 0.0% |
| 2015 Q2 | 978 Thousand AUD | 0.0% |
| 2014 Q4 | 1.59 Million AUD | 210.57% |
| 2014 Q1 | 513.25 Thousand AUD | 0.0% |
| 2014 Q2 | 459 Thousand AUD | -10.57% |
| 2014 FY | 1.84 Million AUD | 34.23% |
| 2014 Q3 | 513.25 Thousand AUD | 11.82% |
| 2013 Q3 | 401.25 Thousand AUD | -31.29% |
| 2013 Q4 | 513.25 Thousand AUD | 27.91% |
| 2013 FY | 1.37 Million AUD | 7.17% |
| 2013 Q1 | 401.25 Thousand AUD | 0.0% |
| 2013 Q2 | 584 Thousand AUD | 45.55% |
| 2012 Q2 | 382.5 Thousand AUD | 0.0% |
| 2012 Q1 | 382.5 Thousand AUD | 0.0% |
| 2012 Q4 | 401.25 Thousand AUD | 4.9% |
| 2012 FY | 1.28 Million AUD | -48.97% |
| 2012 Q3 | 382.5 Thousand AUD | 0.0% |
| 2011 Q4 | 382.5 Thousand AUD | -39.19% |
| 2011 Q3 | 629 Thousand AUD | 0.0% |
| 2011 Q2 | 629 Thousand AUD | 0.0% |
| 2011 FY | 2.51 Million AUD | -46.01% |
| 2011 Q1 | 629 Thousand AUD | 0.0% |
| 2010 FY | 4.66 Million AUD | 378.44% |
| 2010 Q3 | 1.16 Million AUD | 0.0% |
| 2010 Q4 | 629 Thousand AUD | -46.01% |
| 2010 Q1 | 1.16 Million AUD | 0.0% |
| 2010 Q2 | 1.16 Million AUD | 0.0% |
| 2009 Q2 | 167.5 Thousand AUD | 0.0% |
| 2009 Q4 | 1.16 Million AUD | 595.52% |
| 2009 Q3 | 167.5 Thousand AUD | 0.0% |
| 2009 FY | 974 Thousand AUD | -61.16% |
| 2009 Q1 | 167.5 Thousand AUD | 0.0% |
| 2008 Q1 | 423.25 Thousand AUD | 0.0% |
| 2008 Q2 | 423.25 Thousand AUD | 0.0% |
| 2008 Q3 | 423.25 Thousand AUD | 0.0% |
| 2008 Q4 | 167.5 Thousand AUD | -60.43% |
| 2008 FY | 2.5 Million AUD | 58.13% |
| 2007 Q2 | 396.5 Thousand AUD | 0.0% |
| 2007 FY | 1.58 Million AUD | 15.01% |
| 2007 Q1 | 396.5 Thousand AUD | 0.0% |
| 2007 Q3 | 396.5 Thousand AUD | 0.0% |
| 2007 Q4 | 423.25 Thousand AUD | 6.75% |
| 2006 FY | 1.37 Million AUD | 649.46% |
| 2006 Q4 | 396.5 Thousand AUD | 15.01% |
| 2006 Q3 | 344.75 Thousand AUD | 0.0% |
| 2006 Q2 | 344.75 Thousand AUD | 0.0% |
| 2006 Q1 | 344.75 Thousand AUD | 0.0% |
| 2005 Q2 | 46 Thousand AUD | 0.0% |
| 2005 Q4 | 344.75 Thousand AUD | 649.46% |
| 2005 Q3 | 46 Thousand AUD | 0.0% |
| 2005 FY | 184 Thousand AUD | 0.0% |
| 2005 Q1 | 46 Thousand AUD | 0.0% |
| 2004 Q4 | 46 Thousand AUD | 0.0% |
| 2004 FY | - AUD | -100.0% |
| 2004 Q2 | - AUD | 0.0% |
| 2004 Q3 | - AUD | 0.0% |
| 2004 Q1 | - AUD | 0.0% |
| 2003 Q2 | 60.05 Thousand AUD | 0.0% |
| 2003 Q4 | - AUD | -100.0% |
| 2003 Q3 | 60.05 Thousand AUD | 0.0% |
| 2003 Q1 | 60.05 Thousand AUD | 0.0% |
| 2003 FY | 240.2 Thousand AUD | 72.79% |
| 2002 FY | 139.01 Thousand AUD | 0.0% |
| 2002 Q4 | 60.05 Thousand AUD | 72.79% |
| 2002 Q3 | 34.75 Thousand AUD | 0.0% |
| 2002 Q2 | 34.75 Thousand AUD | 0.0% |
| 2002 Q1 | 34.75 Thousand AUD | 0.0% |
| 2001 Q1 | - AUD | 0.0% |
| 2001 FY | - AUD | 0.0% |
| 2001 Q2 | - AUD | 0.0% |
| 2001 Q4 | 34.75 Thousand AUD | 0.0% |
| 2001 Q3 | - AUD | 0.0% |
| 2000 Q3 | - AUD | 0.0% |
| 2000 Q4 | - AUD | 0.0% |
| 2000 FY | - AUD | 0.0% |
| 2000 Q2 | - AUD | 0.0% |
| 2000 Q1 | - AUD | 0.0% |
| 1999 Q3 | - AUD | 0.0% |
| 1999 FY | - AUD | 0.0% |
| 1999 Q1 | - AUD | 0.0% |
| 1999 Q2 | - AUD | 0.0% |
| 1999 Q4 | - AUD | 0.0% |
| 1998 FY | - AUD | 0.0% |
| 1998 Q4 | - AUD | 0.0% |
| 1998 Q3 | - AUD | 0.0% |
| 1998 Q2 | - AUD | 0.0% |
| 1998 Q1 | - AUD | 0.0% |
| 1997 Q2 | - AUD | 0.0% |
| 1997 Q1 | - AUD | 0.0% |
| 1997 Q3 | - AUD | 0.0% |
| 1997 FY | - AUD | 0.0% |
| 1997 Q4 | - AUD | 0.0% |
| 1996 Q2 | - AUD | 0.0% |
| 1996 Q4 | - AUD | 0.0% |
| 1996 Q1 | - AUD | 0.0% |
| 1996 Q3 | - AUD | 0.0% |
| 1996 FY | - AUD | 0.0% |
| 1995 Q4 | - AUD | 0.0% |
| 1995 FY | - AUD | 0.0% |
| 1995 Q1 | - AUD | 0.0% |
| 1995 Q2 | - AUD | 0.0% |
| 1995 Q3 | - AUD | 0.0% |
| 1994 Q3 | - AUD | 0.0% |
| 1994 FY | - AUD | 0.0% |
| 1994 Q1 | - AUD | 0.0% |
| 1994 Q4 | - AUD | 0.0% |
| 1994 Q2 | - AUD | 0.0% |
| 1993 FY | - AUD | 0.0% |
| 1993 Q2 | - AUD | 0.0% |
| 1993 Q4 | - AUD | 0.0% |
| 1993 Q1 | - AUD | 0.0% |
| 1993 Q3 | - AUD | 0.0% |
| 1992 Q4 | - AUD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| AdAlta Limited | 1.73 Million AUD | 72.75% |
| Acrux Limited | 5.09 Million AUD | 90.698% |
| Race Oncology Limited | 4 Million AUD | 88.171% |
| Biome Australia Limited | 13 Million AUD | 96.36% |
| Botanix Pharmaceuticals Limited | 601.82 Thousand AUD | 21.314% |
| BTC Health Limited | 16.36 Thousand AUD | -2794.566% |
| Chimeric Therapeutics Limited | 7.45 Million AUD | 93.65% |
| CSL Limited | 22.41 Billion AUD | 99.998% |
| Clarity Pharmaceuticals Ltd | 11.5 Million AUD | 95.885% |
| Clinuvel Pharmaceuticals Limited | 88.17 Million AUD | 99.463% |
| EZZ Life Science Holdings Limited | 66.44 Million AUD | 99.287% |
| Hexima Limited | - AUD | -Infinity% |
| Immutep Limited | 3.5 Million AUD | 86.492% |
| Memphasys Limited | 60 Thousand AUD | -689.252% |
| Neuren Pharmaceuticals Limited | 231.92 Million AUD | 99.796% |
| Noxopharm Limited | 2.4 Million AUD | 80.271% |
| Prescient Therapeutics Limited | 3.71 Million AUD | 87.244% |
| Radiopharm Theranostics Limited | 299.22 Thousand AUD | -58.258% |
| Starpharma Holdings Limited | 8.28 Million AUD | 94.287% |
| Tissue Repair Ltd | 152.24 Thousand AUD | -211.056% |
| Biotron Limited | - AUD | -Infinity% |
| Alterity Therapeutics Limited | 4.01 Million AUD | 88.218% |
| Anatara Lifesciences Ltd | - AUD | -Infinity% |
| Bio-Gene Technology Limited | 18.32 Thousand AUD | -2484.885% |
| Zelira Therapeutics Limited | 94.95 Thousand AUD | -398.727% |
| Patrys Limited | 1.39 Million AUD | 66.033% |
| Orthocell Limited | 5.31 Million AUD | 91.091% |
| Imugene Limited | - AUD | -Infinity% |
| PYC Therapeutics Limited | 22.05 Million AUD | 97.853% |
| Proteomics International Laboratories Limited | 892.14 Thousand AUD | 46.92% |
| Cynata Therapeutics Limited | 2.31 Million AUD | 79.55% |
| Arovella Therapeutics Limited | 17 Thousand AUD | -2685.594% |
| Nanollose Limited | 12.5 Thousand AUD | -3688.105% |
| Invex Therapeutics Ltd | 1.21 Million AUD | 60.936% |
| NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
| Amplia Therapeutics Limited | 4.45 Million AUD | 89.365% |
| Island Pharmaceuticals Limited | 1.25 Million AUD | 62.164% |
| Nyrada Inc. | - AUD | -Infinity% |
| Telix Pharmaceuticals Limited | 496.65 Million AUD | 99.905% |
| Dimerix Limited | 583.47 Thousand AUD | 18.84% |
| PharmAust Limited | - AUD | -Infinity% |
| AnteoTech Limited | 460.39 Thousand AUD | -2.857% |
| Paradigm Biopharmaceuticals Limited | 65.8 Thousand AUD | -619.682% |
| Recce Pharmaceuticals Ltd | - AUD | -Infinity% |
| Actinogen Medical Limited | 9.93 Million AUD | 95.232% |
| Immuron Limited | 4.9 Million AUD | 90.341% |
| Argenica Therapeutics Limited | 2.59 Million AUD | 81.772% |